SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Anthera Pharmaceuticals, Inc. Announces the Advancement of Blisibimod into Phase 3 Development for Patients With Systemic Lupus Erythematosus (SLE)